반응식
CCCCCCCCCCCCCC(O[C@H]1[C@@]2(OC(C)=O)C(C)(C)[C@H]2[C@@H]2C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@H]3[C@@]2(O)[C@@H]1C)=O.C[C@H]1[C@@H](CC2[O:73][C:72]3[CH:74]=[CH:75][C:76](NC)=[C:77](C(O)=O)[C:71]=3N=2)O[C@]2(O[C@H]([C@@H](C(C3NC=CC=3)=O)C)[C@H](C)C[C@H]2C)CC1.[NH2:83][C@H:84]([C:87]([OH:89])=[O:88])[CH2:85]S>>[NH2:83][C@H:84]([C:87]([OH:89])=[O:88])[CH2:85][C:76]1[CH:77]=[CH:71][C:72]([OH:73])=[CH:74][CH:75]=1참가 물질
4
실험 절차
Reagents Phorbol 12-myristate 13-acetate (PMA) and calcium ionophore A23187 were purchased from Sigma. Bromelain (E.C 3.4.22.4; proteolytic activity, 1,541 nmol/min/mg) was obtained from Solvay Inc. (Germany). E-64 (L-transepoxysuccinylleucylamido-(4-guanidino)butane, a selective cysteine protease inhibitor, was from Sigma.
출처 및 근거
- ORD 기록
- ord-9e75d39f63324d0f83b7112c3b8b39a5
- 출처 데이터셋
- uspto-grants-2010_11
- 특허 번호
- US07833963B2
연결된 노트
불러오는 중…